HomeFile

File

View Category
Structural heart disease

Europe Advances the Transcaval Approach for TAVR

The transfemoral access is clearly the preferred approach to transcatheter aortic valve replacement (TAVR), followed by the...
solaci -
Learn More
Coronary disease

Cath Lab Management Protocol for the COVID-19 Outbreak

The Interventional Cardiology Association and the Cardiac Beat Association from the Spanish Society of Cardiology have released...
solaci -
Learn More
Other

Coronavirus and the Heart: How Should Cardiologists Prepare?

As the number of confirmed cases increases throughout the globe, a picture is emerging as to what...
solaci -
Learn More
Infrapatellar

Drug-Coated Balloons in Infrapopliteal Disease: Much Ado About Nothing

The revascularization of tibial arteries in patients with critical lower limb ischemia using drug-coated balloons vs. conventional...
solaci -
Learn More
Aorta

EVAR with No Complications in Octogenarians: Survival Rate Identical to that of Healthy Octogenarians

This analysis reports (for the first time in the literature) that after the endovascular aortic aneurysm repair...
solaci -
Learn More
Other

Another Scandal in Evidence-Based Medicine: Ambulatory BP Monitoring Questioned?

Apparently, the scandal surrounding the EXCEL trial kicked the hornet’s nest as far as evidence-based medicine is...
solaci -
Learn More
Structural heart disease

Treating Both Atrial Valves Improves Survival

Courtesy of Dr. Carlos Fava. There a few treatment options for tricuspid valve disease. It is practically limited...
solaci -
Learn More
Acute coronary syndromes

Impella and Adverse Events

Long after AHA 2019 had presented observational studies showing adverse events associated to Impella, JAMA is finally...
solaci -
Learn More